Biogen | BIIB - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
AbbVie 23.03 1 2026-03
Acadia Pharmaceuticals 11.61 2.09 2025-12
ALKERMES 19.54 4.64 2025-12
Amgen 25.31 15.82 2025-12
Bayer 5.93 0.68 2025-09
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 19.24 0.21 2025-12
Bristol-Myers Squibb 9.08 0.2 2026-03
Eli Lilly 40.27 0.06 2026-03
Esperion Therapeutics 129.79 129 2024-12
Gilead Sciences 15.63 0.08 2025-12
Incyte 15.35 0.51 2026-03
Merck 13.92 5.08 2025-12
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
Novartis 20.17 2.32 2026-03
Pfizer 14.48 5.18 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Sanofi 11.84 0.14 2026-03
Sanofi 15.75 1.53 2025-12
Sarepta Therapeutics 27.27 0 2025-09
Teva Pharmaceutical Industries 10.07 0.04 2026-03
United Therapeutics 17.32 1.62 2025-12
Vertex Pharmaceuticals 26.15 2.22 2025-12